TB Online is no longer maintained. This is an archive of the site. For news on TB please go to: https://globaltbcab.org/

Items tagged with Scientific research

Shaped like a cone: The configuration of 'virulence factors' that allow TB to invade the lungs (post)

The bacterial pathogen that causes tuberculosis is a master of deception, a king of clever tricks—an enemy agent that not only infiltrates but can become a long-term stowaway in patients' lungs.

Scientists discover how TB puts the brakes on our immune engines (post)

Scientists from Trinity College Dublin have discovered both how TB puts the brakes on our immune engines and how we can kick-start those engines back into gear -- providing hope that improved treatment options could soon be on the horizon.

Blood test for eight gene signatures could predict onset of TB (post)

Scientists at UCL have shown a blood test could predict the onset of tuberculosis three to six months before people become unwell, a finding which could help better target antibiotics and save countless lives.

GSK licenses TB vaccine candidate to the Bill & Melinda Gates Medical Research Institute for continued development (post)

-- The M72/AS01E tuberculosis vaccine candidate demonstrated in a phase IIb trial the potential to reduce active pulmonary TB by half in adults with latent TB infection.[1]
-- Developing a new vaccine against TB is a global health priority to accelerate progress toward ending the TB epidemic[2] and one of the United Nations Sustainable Development Goals
-- The licensing agreement is a significant step forward to continue the development of the vaccine candidate for low-income countries with high TB burdens.

ERA4TB to accelerate the development of comprehensive treatments against TB (post)

With a team of more than thirty public and private organisations and a budget over 200 million euro, ERA4TB aims to radically transform the way in which new therapies are developed for the treatment of tuberculosis.

Immune responses to TB mapped across 3 species (post)

Tuberculosis (TB) is one of the world’s most vexing public health problems. About 1.5 million people died from this bacterial lung infection in 2018, and the World Health Organization (WHO) estimates that one-quarter of the world’s population — some 2 billion people, mostly in developing countries — are infected with the bacteria that causes TB.

Immunitor unveils breakthrough immunotherapy to treat TB in as short as one month (post)

VANCOUVER, British Columbia, February 01, 2020

Page 45 of 74 · Total posts: 0

←First 44 45 46 Last→